Alendronate use in older patients with reduced renal function: challenges and opportunities in clinical practice.

Naganathar, N; Yau, W -P; Mok, Z H; Tan, Z Y F; Chew, S T H

Naganathar, N; Yau, W -P; Mok, Z H; Tan, Z Y F; Chew, S T H.

Afiliação

Naganathar N; Department of Pharmacy, Changi General Hospital, 2 Simei Street 3, Singapore, 529889, Singapore. niron.naganathar@u.nus.edu.
Yau W-; Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore, Singapore.
Mok ZH; Department of Pharmacy, Changi General Hospital, 2 Simei Street 3, Singapore, 529889, Singapore.
Tan ZYF; Department of Pharmacy, Changi General Hospital, 2 Simei Street 3, Singapore, 529889, Singapore.
Chew STH; Department of Geriatric Medicine, Changi General Hospital, Singapore, Singapore.

Osteoporos Int ; 32(10): 1981-1988, 2021 Oct.

Article em En | MEDLINE | ID: mdl-33721033

Assuntos

Alendronato; Insuficiência Renal; Idoso; Alendronato/efeitos adversos; Difosfonatos/efeitos adversos; Humanos; Rim/fisiologia; Estudos Retrospectivos

Palavras-chave

Alendronate; Bisphosphonates; Elderly; Osteoporosis; Renal impairment

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Alendronato / Insuficiência Renal Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Osteoporos Int Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Singapura

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google